Leading TCR Immuno-oncology Biotech shows Promising Results against Cancer
Cell-based Immune-oncology therapies continue to deliver amazing results. After Cellectis wondersaving from last week, Oxford's…
November 9, 2015 - 2 minutes
Cell therapy
Keep yourself up to date with the latest cell therapy news, including stem cell therapy, CAR-T cell therapy, and more. This section covers the latest updates on regulations, deals, and technology advancements of cell therapy companies.
€1.37Bn Deal for Sanofi with Germany’s Fastest Growing mRNA Cancer Biotech
Sanofi is now the latest Biotech lining up to partner with BioNTech from Mainz (Germany),…
November 4, 2015 - 3 minutes
Biotech of the week: Mologen, the Largest Publicly-listed Biotech of Berlin
This week, we're leaving Paris and heading East to a city that's 9 times bigger than…
October 16, 2015 - 2 minutes
Louvain-la-Neuve: A Belgian temple for success in cell therapy
Artificial three-dimensional tissues to regenerate bones and soft tissues: Novadip Biosciences’ dream is a step…
September 15, 2015 - 2 minutes
Adaptimmune’s TCR Therapy Proves its Superiority over its Immuno-oncology Competitors
Adaptimmune Therapeutics, an oxford-based company focusing on the use of T-cell therapies to treat cancer,…
July 22, 2015 - 3 minutes
Medigene plans to fund its T-cell program with €50 Millions
Munich-based Medigene is planning to raise cash through existing shareholders’ investments. The company targets up…
June 22, 2015 - 2 minutes
Pluristem accelerates its Cell Therapy program thanks to the EMA
Pluristem Therapeutics has good reasons to celebrate: its PLX cell program in critical limb ischemia…
May 24, 2015 - 2 minutes
[UPDATE] Adaptimmune raised €156.7M in its IPO
Oxford-based Adaptimmune has launched its IPO on NASDAQ, where the immunotherapist plans to raise about €156.7M. The company…
May 13, 2015 - 2 minutes
US-based Juno Therapeutics purchased a German biotech
Juno Therapeutics has purchased Stage Cell Therapeutics, a privately held biotechnology company, based in Munich…
May 12, 2015 - 2 minutes
Important Bilateral Academic Agreement for the Future of iPS Cell Therapy
The UK Cell Therapy programme Catapult, which is focused on the development of the UK…
January 24, 2015 - 3 minutes
Promethera Biosciences Raised €25,33M to Treat Liver Diseases
Promethera Biosciences, a Belgian biotechnology company developing Promethera HepaStem, a cell-based therapy for the treatment…
November 25, 2014 - 2 minutes
